REMISSION OF TYPE 2 DIABETES (T2DM) IN 33.6% (51 OF 152) HYPOGONADAL MEN RECEIVING LONG-TERM TESTOSTERONE THERAPY FOR UP TO 12 YEARS IN A REAL-LIFE REGISTRY STUDY

被引:0
|
作者
Haider, K. S. [1 ]
Haider, A. [1 ]
机构
[1] Praxis Dr Haider, Bremerhaven, Germany
来源
JOURNAL OF SEXUAL MEDICINE | 2020年 / 17卷 / 01期
关键词
D O I
10.1016/j.jsxm.2019.11.220
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
375
引用
收藏
页码:S104 / S104
页数:1
相关论文
共 50 条
  • [21] Effects of Long-term Testosterone Treatment on the Lipid Pattern in hypogonadal Men with Type 2 Diabetes (T2D) in a urological Registry Study
    Saad, Farid
    Haider, Karim Sultan
    Haider, Ahmad
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 217 - 217
  • [22] Prevalence of type 2 diabetes and prediabetes in hypogonadal men and effects of testosterone treatment: real-life experience from a controlled registry study
    Wissinger, U.
    Yassin, A.
    Doros, G.
    Saad, F.
    DIABETOLOGIA, 2017, 60 : S395 - S396
  • [23] EFFECTS OF LONG-TERM TESTOSTERONE THERAPY ON ERECTILE FUNCTION, SEXUAL ACTIVITY, AND QUALITY OF LIFE IN HYPOGONADAL MEN WITH TYPE 2 DIABETES - RESULTS FROM A REGISTRY STUDY
    Haider, A.
    Haider, K. S.
    Doros, G.
    Traish, A.
    Saad, F.
    JOURNAL OF SEXUAL MEDICINE, 2023, 20
  • [24] Improvement of type 2 diabetes in hypogonadal men with long-term testosterone therapy (TTh) is sustained for up to 10 years compared to untreated controls
    Wissinger, U.
    Haider, A.
    Haider, K. S.
    Doros, G.
    Traish, A.
    Saad, F.
    DIABETOLOGIA, 2018, 61 : S328 - S328
  • [25] Significant reduction of Framingham risk score in hypogonadal men receiving long-term testosterone therapy: real-life evidence from a 10-year registry
    Saad, F.
    Haider, A.
    Haider, K. S.
    Huang, K.
    Xu, X.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1056 - 1056
  • [26] IMPROVEMENT AND STABILIZATION OF ERECTILE FUNCTION, ANTHROPOMETRIC AND METABOLIC PARAMETERS IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM) ON LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS
    Saad, F.
    Doros, G.
    Haider, A.
    Traish, A.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 245 - 246
  • [27] URINARY AND ERECTILE FUNCTION IMPROVEMENTS IN HYPOGONADAL MEN WITH TYPE 2 DIABETES (T2DM) TREATED UP TO 10 YEARS WITH TESTOSTERONE IN COMPARISON TO AN UNTREATED CONTROL GROUP
    Haider, Ah
    Haider, Karim
    Doros, Gheorghe
    Traish, Abdulmaged
    Saad, Farid
    JOURNAL OF UROLOGY, 2019, 201 (04): : E467 - E468
  • [28] ERECTILE FUNCTION IMPROVES IN HYPOGONADAL MEN WITH TYPE 2 DIABETES UNDER LONG-TERM TESTOSTERONE THERAPY: REAL-WORLD EVIDENCE FROM A UROLOGICAL REGISTRY STUDY
    Saad, F.
    Haider, K. S.
    Doros, G.
    Traish, A.
    Haider, A.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S169 - S170
  • [29] IN OBESE HYPOGONADAL MEN, LONG-TERM TESTOSTERONE THERAPY IMPROVES ERECTILE FUNCTION, QUALITY OF LIFE AND BODY WEIGHT - REAL-LIFE EVIDENCE FROM A REGISTRY STUDY
    Saad, F.
    Haider, A.
    Haider, K. S.
    Doros, G.
    Traish, A.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S168 - S169
  • [30] Remission of Type 2 Diabetes after Long-Term Testosterone Therapy
    Hanefeld, Markolf
    Haider, Ahmad
    Zitzmann, Michael
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (01): : 33 - 37